New vaccine approved to prevent meningococcal disease
Links shared publicly online about this topic.
- 1,361total visits
New vaccine approved to prevent meningococcal disease
View full resource at pediatricsupersite.com
Tags: Vaccination, Disease and Condition, FDA, Vaccine, Novartis
Most Recently Shared on February 23, 2010 at 3:00 pm By:
New vaccine approved to prevent #meningococcal disease: http://ow.ly/1ak18 #Menveo #Novartis
The HPV Vaccine: Access and Use in the U.S. - Kaiser Family Foundation
kff.org — “The Food and Drug Administration has approved two vaccines against infection by certain strains of human papillomavirus (HPV), the most common sexually transmitted infection in the United States. Initially, the vaccines were recommended only for girls and young women, but in 2011 the Centers for Disease Control and Prevention broadened them to include boys and young men. The fact sheet discusses HPV and cancers related to the virus, use of the HPV vaccines for both females and males, and insuran” View full resource at kff.org
Most Recently Shared on November 22, 2011 at 6:36 pm By:
HPV Vaccine Fact Sheet Discusses New Recommendation for Vaccinating Boys via KFF: http://t.co/4DpKQQdp
FDA Votes to Extend Pneumonia Vaccine to Adults – TIME Healthland
healthland.time.com — “A panel of federal health experts voted overwhelmingly Wednesday to recommend that Pfizer's best-selling vaccine be approved for a new use in preventing pneumococcal disease in adults age 50 and older.” View full resource at healthland.time.com
Most Recently Shared on November 17, 2011 at 5:25 pm By:
AmericanCollSurgeons Medical Society
FDA Votes to Extend Pneumonia Vaccine to Adults: http://t.co/xaPN9ydo #pneumonia #vaccine #FDA
Meningococcal Vaccine Now Approved for Use in Infants | Health News
healthnews.com — “Today the FDA approved the use of Menactra in children as young as nine months for the prevention of invasive meningococcal disease. While the vaccine has been previously available to people over the age of two, it is now approved for use in children as young as nine months.” View full resource at healthnews.com
Most Recently Shared on April 25, 2011 at 4:50 pm By:
Meningococcal Vaccine Now Approved for Use in Infants http://ht.ly/4Gv6g
FDA approves meningococcal vaccine for infants and toddlers
pediatricsupersite.com — “The FDA has approved a vaccine for the prevention of invasive meningococcal disease caused by certain serogroups of Neisseria meningitidis for u” View full resource at pediatricsupersite.com
Most Recently Shared on April 25, 2011 at 3:25 pm By:
Pediatric SuperSite Health Site
FDA approves meningococcal vaccine for infants and toddlers http://ow.ly/4GpzI
Menactra, Meningococcal Vaccine For Infants From 9 Months Approved By FDA
medicalnewstoday.com — “Menactra, a vaccine for the prevention of invasive meningococcal disease for children from 9 months of age has been approved by the FDA (Food and Drug Administration). The vaccine, which is alread” View full resource at medicalnewstoday.com
Most Recently Shared on April 23, 2011 at 3:05 pm By:
MNT Pediatrics News Pediatrics and Health News
Menactra, Meningococcal Vaccine For Infants From 9 Months Approved By FDA http://mnt.to/3TYg #pediatrics
FDA Approves The First Vaccine To Prevent Meningococcal Disease In Infants And Toddlers
medicalnewstoday.com — “The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis sero” View full resource at medicalnewstoday.com
Most Recently Shared on April 23, 2011 at 7:05 am By:
MNT Infect Diseases Health News
FDA Approves The First Vaccine To Prevent Meningococcal Disease In Infants And Toddlers http://mnt.to/3TYf #viruses #bacteria
Menveo meningococcal vaccine approved for children - ONA
oncologynurseadvisor.com — “Novartis announced that the FDA has approved Menveo (meningococcal [Groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in children 2--10 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 1, 2011 at 4:17 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Menveo meningococcal vaccine approved for children http://goo.gl/fb/UUtBV
Menveo meningococcal vaccine approved for children - MPR
empr.com — “Novartis announced that the FDA has approved Menveo (meningococcal [Groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in children 2--10 years of age.” View full resource at empr.com
Most Recently Shared on February 1, 2011 at 3:43 pm By:
MPR News: Menveo meningococcal vaccine approved for children: Novartis announced that the FDA has approved Menve... http://bit.ly/eJpIuF
New recommendations for MCV4 use - Related Stories - AAP SmartBrief
smartbrief.com — “The AAP Committee on Infectious Diseases approved two new modifications for the use of quadrivalent meningococcal vaccines (MCV4, Menactra, and Menveo) recommended by the Advisory Committee on Immunization Practices of the CDC. These new recommendations will affect the 2011 immunization schedule. De” View full resource at smartbrief.com
Most Recently Shared on January 31, 2011 at 4:17 pm By:
Clara Song Physician, Doctor, and Pediatrician
New recommendations for MCV4 use http://sbne.ws/r/6CiV
Health Canada approves Novartis' Menveo for prevention of meningococcal disease
news-medical.net — “Novartis Pharmaceutical Canada Inc. announced that Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by Health Canada for active immunization of adolescents (11 to 18 years of age) and adults (19 to 55 years of age) to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.” View full resource at news-medical.net
Most Recently Shared on June 8, 2010 at 6:19 pm By:
Meningitis News: Health Canada approves Novartis' Menveo for prevention of meningococcal disease: Novartis Pharmac... http://bit.ly/cktD6u
Symposier - New Pneumococcal Vaccine for Children
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA has approved a new pneumococcal vaccine that provides broader protection for infants and young children ages six weeks through five years. The new vaccine, called Prevnar 13, is effective against 13 serotypes of the bacterium Streptococcus pneumoniae. It will replace Prevnar, which was effective against seven serotypes. Prevnar 13 is approved to prevent invasive pneumococcal disease, including bacterial meningitis and bacteremia, caused b” View full resource at symposier.com
Most Recently Shared on May 21, 2010 at 6:04 pm By:
FDA - New Pneumococcal Vaccine for Children. http://bit.ly/cML6lF
Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease
novartis.com — “Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease” View full resource at novartis.com
Most Recently Shared on March 18, 2010 at 7:14 am By:
Novartis Menveo is 1st quadrivalent conjugate vaccine approved in EU to help prevent meningococcal disease: http://bit.ly/cbKt7t
FDA Approves Pneumococcal Disease Vaccine with Broader Protection
fda.gov — “The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.” View full resource at fda.gov
Most Recently Shared on February 24, 2010 at 6:31 pm By:
Len Leshin Pediatrician, Physician, and Doctor
FDA approves new #Pneumococcal Vaccine with Broader Protection for infants, toddlers http://bit.ly/9as7JB #pediatrics #Prevnar
Novartis Receives FDA Approval Of Menveo®, A Vaccine To Prevent Meningococcal Disease
medicalnewstoday.com — “Novartis announced that Menveo® (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by t” View full resource at medicalnewstoday.com
Most Recently Shared on February 23, 2010 at 10:10 pm By:
MNT Clinical Trials Health News
Novartis Receives FDA Approval Of Menveo®, A Vaccine To Prevent Meningococcal Disease http://mnt.to/3xY6 #clinicaltrials
Advertisement
